| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Group Chief Exec - Health &Ps | Grp Chief Exec-health &Ps
1 company
London Daniel T is a Group Chief Exec - Health &Ps at Accenture plc. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $2.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2017 | ACN Accenture Plc | Group Chief Exec - Health &Ps | Sell | 637 | $136.03 | $86,649.71 | -2.7% | |
| Jul 24, 2017 | ACN Accenture Plc | Group Chief Exec - Health &Ps | Sell | 4,808 | $128.05 | $615,685.56 | -17.5% | |
| Apr 6, 2017 | ACN Accenture Plc | Grp Chief Exec-health &Ps | Sell | 697 | $117.29 | $81,750.01 | -2.5% | |
| Jan 6, 2017 | ACN Accenture Plc | Grp Chief Exec-health &Ps | Sell | 4,437 | $115.87 | $514,113.65 | -4.8% | |
| Dec 23, 2016 | ACN Accenture Plc | Grp Chief Exec-health &Ps | Sell | 5,549 | $117.65 | $652,864.82 | -20.9% | |
| Jul 20, 2016 | ACN Accenture Plc | Grp Chief Exec-health &Ps | Sell | 3,686 | $115.57 | $425,995.72 | -7.1% | |
| Apr 6, 2016 | ACN Accenture Plc | Grp Chief Exec-health &Ps | Sell | 5,363 | $114.46 | $613,863.46 | -16.4% | |
| Dec 29, 2015 | ACN Accenture Plc | Grp Chief Exec-health &Ps | Sell | 891 | $104.99 | $93,544.13 | -3.5% | |
| Oct 5, 2015 | ACN Accenture Plc | Grp Chief Exec-health &Ps | Sell | 1,211 | $101.13 | $122,468.01 | -2.8% | |
| Jul 20, 2015 | ACN Accenture Plc | Grp Chief Exec-health &Ps | Sell | 3,446 | $100.70 | $347,010.48 | -14.1% |